The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 70.00
Bid: 60.00
Ask: 80.00
Change: 0.00 (0.00%)
Spread: 20.00 (33.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 70.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Jan 2022 07:00

RNS Number : 7603Z
Biome Technologies PLC
27 January 2022
 

This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

27 January 2022

Biome Technologies plc

("Biome", "the Company" or "the Group")

Trading Update

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today provides an unaudited pre-close trading update for the financial year ended 31 December 2021.

Group revenues for the year ended 31 December 2021 were in line with current market expectations at £5.6m (2020: £5.7m) and cash balances at the year-end of £1.0m were ahead of those expectations (31 December 2020: £1.7m) because of receipts of deposits from customers and improved working capital management. The Group continues to have no external bank borrowings.

The Board anticipates that, subject to audit, the Group will generate a loss before interest, taxation, depreciation, amortisation and share option charges for the year ended 31 December 2021 that is in line with current market expectations.

The Group's preliminary results for the year ended 31 December 2021 are scheduled to be published on 24 March 2022.

Bioplastics Division

The division's revenues for the full year to 31 December 2021 were £4.7m (2020: £4.9m), reflecting the previously highlighted global logistics issues and delays in the implementation of new projects as customers manage their own supply chain problems.

Revenues in Q4 were £1.6m, 35% ahead of the prior year comparative quarter (Q4 2020: £1.2m), and substantially greater than the preceding quarter (Q3 2021: £0.8m). The Board expects revenues in 2022 to be weighted more towards the second half of the year as revenues from new and existing customer implementations are expected to increase.

Stanelco RF Technologies Division

Revenues in the RF Technologies division in Q4 were £0.4m, ahead of the preceding quarter's revenue of £0.3m, and greater than the prior year comparable (Q4 2020: £0.3m). Revenues for the division for the full year to 31 December 2021 were £0.9m (2020: £0.8m).

Trading is expected to be particularly productive during the first half of 2022 as the recently announced new orders both for fibre optic furnaces and wider industrial applications are delivered.

Group Outlook

The Group ended 2021 with a lower level of revenues than was expected when the year started. However, the Directors are pleased with the improved cash position of the Group which they currently believe should enable Biome to capitalise on the orderbook and pipeline in both divisions. 

The scale of opportunities available to Biome is now greater than it was at this time last year and the Board remains confident of being able to build on the Group's prospects during 2022 and thereafter.

 

- Ends -

 

For further information please contact: Biome Technologies plc

Paul Mines, Chief Executive Officer

Rob Smith, Chief Financial Officer

info@biometechnologiesplc.co.uk

Tel: +44 (0) 2380 867 100

www.biometechnologiesplc.com

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)

Tel: +44 (0) 20 3328 5656

www.allenbycapital.com

 

About Biome

 

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

 

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited.

 

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers.

 

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

 

www.biometechnologiesplc.com

www.biomebioplastics.com and www.thinkbioplastic.com 

www.stanelcorftechnologies.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKABDOBKDKDB
Date   Source Headline
1st Aug 20057:01 amRNSDirector Appointment
28th Jul 20057:01 amRNSUpdate re: trials with ASDA
26th Jul 20057:00 amRNSContract Win
19th Jul 20057:00 amRNSRe Agreement
5th Jul 20057:01 amRNSRe Joint Venture
29th Jun 20057:00 amRNSInterim Results
22nd Jun 20057:00 amRNSUpdate re trials with Asda
8th Jun 20055:29 pmRNSAdditional Listing
8th Jun 200510:00 amRNSAppointment of Group MD
8th Jun 20057:50 amRNSPlacing of Ordinary Shares
6th Jun 20057:01 amRNSAcquisition
3rd Jun 20053:02 pmRNSIssue of Equity
23rd May 20057:01 amRNSRe Contract
17th May 200512:12 pmRNSAdditional Listing
10th May 20057:00 amRNSUpdate re. trials with Asda
29th Apr 20053:46 pmRNSHolding(s) in Company
25th Apr 20053:27 pmRNSDirector Shareholding
22nd Apr 20052:24 pmRNSResult of AGM
22nd Apr 200511:31 amRNSAGM Statement
11th Apr 20057:00 amRNSRe Agreement
7th Apr 20057:00 amRNSRe Agreement
6th Apr 200512:41 pmRNSAdditional Listing
24th Mar 20057:00 amRNSRe Contract
22nd Mar 20054:49 pmRNSAnnual Report and Accounts
21st Mar 20057:02 amRNSStatement on High Court
1st Mar 20057:01 amRNSUpdate re. trials with Asda
28th Feb 20057:00 amRNSFinal Results
23rd Feb 20054:45 pmRNSAdditional Listing
9th Feb 20053:16 pmRNSAgreement and Placing
8th Feb 20057:00 amRNSUpdate re. trials with Asda
31st Jan 20059:09 amRNSRe. Agreement
25th Jan 20057:00 amRNSDirectorate Change
17th Jan 200511:44 amRNSAdditional Listing
4th Jan 200511:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.